Hijacking the host heparan sulfate-cell-surface ribonucleoproteins (RNPs) scaffold pathway for viral immune evasion Authors: Wei Ye, Yangchao Dong, He Liu, Hongwei Ma, Yingfeng Lei, Fanglin Zhang Published: 2026 ABSTRACT Highlights•Viral nucleocapsid proteins may co-opt this host scaffold for cell-surface display.•Surface-displayed viral proteins can bind chemokines, suppressing immune cell recruitment. Li and Joshi et al. recently defined the biochemical basis for cell-surface RNA (csRNA) presentation in a recent issue of Molecular Cell (Li et al., 2025). Their work identifies heparan sulfate (HS) as a critical scaffold for endogenous RNA-binding protein (RBP) complexes, revealing the cell surface as a dedicated platform for recruiting immune receptors such as KIR2DL5 to tune immune signaling (Fig. 1). This host-derived molecular architecture provides a unifying conceptual framework to address a long-standing paradox in virology: the widespread cell-surface display of viral nucleocapsid (N) proteins on infected cells, a phenomenon first reported over four decades ago (Virelizier et al., 1977), and comprehensively contextualized in a recent authoritative review (López-Muñoz and Yewdell, 2024). A model of viral subversion of the host HS-RNP scaffold for immune evasion. The physiological HS-csRNA-RBP complex that mediates immune tuning via recruitment of host immune receptors (left). Viral infection leads to the replacement of host RBPs by viral nucleocapsid (N) proteins on the HS scaffold, creating a surface complex that acts as a chemokine sink to bind and neutralize pro-inflammatory chemokine (CXCL12), thereby blocking immune cell recruitment and enabling viral immune evasion (right). For decades, the presence of these strictly intracellular viral antigens on the plasma membrane was dismissed as a technical artifact or a passive consequence of cell lysis. This phenomenon has now been documented for N proteins from diverse RNA virus families, including influenza A virus, HIV-1, measles virus, and most extensively, SARS-CoV-2 and HCoV-OC43 (Virelizier et al., 1977; López-Muñoz et al., 2022, 2023). As highlighted by López-Muñoz and Yewdell, this conserved phenotype points to a deliberate and convergent evolutionary strategy across diverse RNA virus families (López-Muñoz and Yewdell, 2024). The findings of Li and Joshi et al. now provide a mechanistic basis for this phenomenon: viral N proteins may actively co-opt the host HS-RNP network, converting an endogenous immune regulatory interface into a dedicated mechanism for viral immunosuppression (Fig. 1). The mechanistic parallels between host csRNA-RNP complexes and viral surface N assemblies are striking. Li and Joshi et al. demonstrate that HS acts as the core scaffold stabilizing the extracellular csRNA-RBP ternary complex. Correspondingly, the N proteins of SARS-CoV-2 and HCoV-OC43 have been experimentally validated to contain high-affinity heparin/HS-binding domains that directly mediate their stable retention on the cell surface (López-Muñoz et al., 2022, 2023). While surface-displayed N proteins from other RNA virus families (including respiratory syncytial virus and measles virus) have been reported to engage distinct host surface receptors (e.g., T cell receptor and FcγRII, respectively) to modulate immunity (López-Muñoz and Yewdell, 2024), we hypothesize that HS-mediated surface anchoring represents a broadly conserved strategy for viral N proteins to achieve stable extracellular display. This shared dependence on the HS scaffold also resolves a key question: how these large, typically intracellular ribonucleoprotein assemblies remain stably presented in the highly dynamic extracellular environment. A functional parallel also exists between the host and viral surface complexes, albeit with opposing immunological outcomes. Li and Joshi et al. show that the host HS-csRNA-RNP platform tunes immune homeostasis by recruiting immunomodulatory receptors such as KIR2DL5. Viruses appear to have evolved a mirroring yet antagonistic strategy: they exploit the same HS scaffold to anchor N proteins that act as high-affinity chemokine sinks. To date, this chemokine-sequestering activity has been experimentally validated for the surface-displayed N proteins of SARS-CoV-2 and HCoV-OC43, which bind a defined panel of human chemokines with micromolar to nanomolar affinity (López-Muñoz et al., 2022; López-Muñoz et al., 2023). Among these chemokine targets, direct inhibition of chemotactic activity has been experimentally demonstrated for CXCL12 (Fig. 1) (López-Muñoz et al., 2022, 2023). CXCL12 (also known as stromal cell-derived factor 1, SDF-1) is a homeostatic and inflammatory CXC chemokine that signals primarily via the G protein-coupled receptor CXCR4, with secondary regulatory signaling via the atypical chemokine receptor ACKR3 (CXCR7) (Cambier et al., 2023). CXCR4 is constitutively and highly expressed on multiple innate and adaptive immune effector cells with critical roles in antiviral immunity, including CD4+ helper and CD8+ cytotoxic T lymphocytes, natural killer (NK) cells, circulating classical and non-classical monocytes, conventional and plasmacytoid dendritic cells (DCs), and mature B cells (Moll and Ransohoff, 2010; Cambier et al., 2023; Korbecki et al., 2024). The CXCL12-CXCR4 axis is a well-characterized regulator of immune cell trafficking, serving as a key signal for recruiting circulating effector cells from the bloodstream into the infected peripheral tissues. CCL21 is a homeostatic CC chemokine that exerts its chemotactic effects exclusively via the CCR7 receptor, a key regulator of adaptive immune priming and tissue immunosurveillance (Hauser and Legler, 2016; Han and Zhang, 2023). CCR7 is rapidly upregulated on DCs upon maturation and antigen uptake, and is constitutively highly expressed on naïve T cells, central memory T cells, and mature B cells (Hauser and Legler, 2016). The CCL21-CCR7 axis drives two core processes essential for protective antiviral immunity: first, it mediates the migration of antigen-bearing mature DCs from infected peripheral tissues to draining lymph nodes; second, it directs the co-localization of these antigen-presenting DCs with naive T cells to initiate antigen-specific adaptive immune responses (Nguyen et al., 2017). High-affinity binding of CXCL12 and CCL21 by surface-anchored N proteins directly sequesters these chemokines away from their cognate receptors, disrupting the formation of stable, directional chemotactic gradients (Griffith et al., 2014). This blockade impairs both the recruitment of circulating innate and adaptive effector immune cells to the infected microenvironment and the initiation of antigen-specific antiviral immunity in draining lymph nodes. Together, these effects enable viral immune evasion by blunting both the immediate innate response and the development of long-term protective adaptive immunity. Beyond this functional convergence in immune modulation, the biogenesis of these complexes presents another striking parallel in their secretory route. Both the host csRNA-RBPs characterized by Li and Joshi et al. and viral N proteins reach the cell surface without traversing the conventional ER-Golgi secretory pathway, in contrast to N-glycan-modified RNAs (Flynn et al., 2021). The central role of HS as an extracellular anchor further supports a model of unconventional protein secretion (UPS), in which high extracellular affinity for HS drives the translocation of otherwise intracellular RNP complexes across the plasma membrane (Zhang et al., 2020; Sparn et al., 2022). In summary, Li and Joshi et al. have elucidated the core biochemical mechanism underlying stable cell-surface RNP presentation. Exploring how viruses subvert this endogenous host system to evade immunity presents a dual transformative prospect: it advances our fundamental understanding of extracellular RNA biology, and pinpoints HS-N protein engagement as a novel, potential target for broad-spectrum antiviral strategies. Subsequent studies may productively examine whether pharmacologically disrupting HS-N protein interactions can reinstate chemotactic signaling within the infected tissue microenvironment. Footnotes This work was supported by the National Natural Science Foundation of China (nos. 32570160, 31600131, 82172272, and 81871649). The funders had no role in the publication decision, or manuscript preparation. Footnotes Peer review under the responsibility of editorial board of Virologica Sinica. Contributor Information Wei Ye, Email: virologyyw@fmmu.edu.cn. Fanglin Zhang, Email: flzhang@fmmu.edu.cn. References